2014 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

First Patient Enrolled in United States Study of Novate’s Sentry IVC Filter

September 22, 2014—Novate Medical announced the beginning of enrollment in the SENTRY investigational device exemption (IDE) study, a prospective, single-arm, multicente…

FDA Approves Indication for Gore’s Viabahn to Treat In-Stent Restenosis in SFA

September 22, 2014—Gore & Associates announced that the US Food and Drug Administration (FDA) has approved the Gore Viabahn endoprosthesis for interventional treatme…

Straub Medical’s Rotarex S and Aspirex S Catheters Approved in Brazil

September 18, 2014—Straub Medical AG announced that the Brazilian Health Surveillance Agency (ANVISA) has approved the company’s Rotarex S and Aspirex S rotational…

SIMPLICITY FLEX Studies Renal Denervation for Mild Refractory Hypertension

September 16, 2014—At the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, DC, results from the SIMPLICITY FLEX trial were…

EXCITE ISR Supports Spectranetics Laser Atherectomy System in Femoropopliteal ISR

September 16, 2014—The EXCITE ISR trial, the first large prospective study to examine the effectiveness of laser atherectomy for the treatment of femoropopliteal in-sten…

Findings Reported From Studies of Medtronic’s In.Pact Admiral DCB Treatment for SFA

September 16, 2014—Medtronic, Inc. announced that the latest clinical and economic data on the In.Pact Admiral drug-coated balloon (DCB) were presented for the first tim…

CARENET 30-Day Data Presented for InspireMD’s CGuard EPS

September 16, 2014—InspireMD, Inc. announced positive results from the CARENET trial for its CGuard embolic protection system (EPS). This trial demonstrates that th…

Click here for more News coverage

Current Supplements

United States

Sponsored by BARD PERIPHERAL VASCULAR, INC.

Seeing Is Believing

An in-depth look at the science and clinical use of the Crosser® CTO Recanalization Catheter

Europe

Sponsored by CORDIS CORPORATION

Reengineering the Art of EVAR

Achieving durable, low-profile repair with the INCRAFT® AAA Stent Graft System.

physician counsel

How Physicians Can Dispute Open Payments Data

How can you keep erroneous information about your industry payments from becoming front-page news?

What's Lurking in Your Industry Contracts?

Factors to consider before signing your next consulting agreement.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media